 | • レポートコード：QFJ1-3940 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、乳がん検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（スクリーニング検査、診断検査、モニタリング検査）、用途別市場規模（非浸潤性乳がん、浸潤性乳がん）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・乳がん検査の市場動向 ・企業の競争状況、市場シェア ・乳がん検査の種類別市場規模と予測2016-2027（スクリーニング検査、診断検査、モニタリング検査） ・乳がん検査の用途別市場規模と予測2016-2027（非浸潤性乳がん、浸潤性乳がん） ・乳がん検査の北米市場規模2016-2027（アメリカ、カナダ） ・乳がん検査の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・乳がん検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・乳がん検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・乳がん検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、Alere、Becton Dickinson、BioMerieux、Roche、GE Healthcare、Hologic、Philips、PerkinElmer、Quest Diagnostics） ・結論 |
Breast cancer is one of the most common malignant tumors in women, which poses a great threat to women’s life and health.In recent years, as people pay more attention to women’s health, the detection methods of their diseases have been greatly improved.Breast cancer tests include screening tests, diagnostic tests and monitoring tests.Screening tests, such as annual mammograms, are given regularly to people who appear healthy and who are not suspected of having breast cancer.The goal is to detect breast cancer early, before any symptoms appear, and cancer is often easier to treat.Diagnostic tests (such as biopsies) are for people suspected of having breast cancer (such as biopsies).These tests are used to determine whether breast cancer is present and, if so, whether it has reached the outside of the breast.Diagnostic tests are also used to gather more information about cancer to guide treatment decisions.Once breast cancer is diagnosed, many tests are used during and after treatment to monitor how well therapies are working. Monitoring tests also may be used to check for any signs of recurrence.
Market Analysis and Insights: Global Breast Cancer Testing Market
The global Breast Cancer Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Breast Cancer Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Breast Cancer Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Breast Cancer Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Breast Cancer Testing market.
Global Breast Cancer Testing Scope and Market Size
Breast Cancer Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Breast Cancer Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Screening Tests
Diagnostic Tests
Monitoring Tests
Segment by Application
Non-invasive Breast Cancer
Invasive Breast Cancer
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott
Alere
Becton Dickinson
BioMerieux
Roche
GE Healthcare
Hologic
Philips
PerkinElmer
Quest Diagnostics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Breast Cancer Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Screening Tests
1.2.3 Diagnostic Tests
1.2.4 Monitoring Tests
1.3 Market by Application
1.3.1 Global Breast Cancer Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Non-invasive Breast Cancer
1.3.3 Invasive Breast Cancer
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Breast Cancer Testing Market Perspective (2016-2027)
2.2 Breast Cancer Testing Growth Trends by Regions
2.2.1 Breast Cancer Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Breast Cancer Testing Historic Market Share by Regions (2016-2021)
2.2.3 Breast Cancer Testing Forecasted Market Size by Regions (2022-2027)
2.3 Breast Cancer Testing Industry Dynamic
2.3.1 Breast Cancer Testing Market Trends
2.3.2 Breast Cancer Testing Market Drivers
2.3.3 Breast Cancer Testing Market Challenges
2.3.4 Breast Cancer Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Breast Cancer Testing Players by Revenue
3.1.1 Global Top Breast Cancer Testing Players by Revenue (2016-2021)
3.1.2 Global Breast Cancer Testing Revenue Market Share by Players (2016-2021)
3.2 Global Breast Cancer Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Breast Cancer Testing Revenue
3.4 Global Breast Cancer Testing Market Concentration Ratio
3.4.1 Global Breast Cancer Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Breast Cancer Testing Revenue in 2020
3.5 Breast Cancer Testing Key Players Head office and Area Served
3.6 Key Players Breast Cancer Testing Product Solution and Service
3.7 Date of Enter into Breast Cancer Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Breast Cancer Testing Breakdown Data by Type
4.1 Global Breast Cancer Testing Historic Market Size by Type (2016-2021)
4.2 Global Breast Cancer Testing Forecasted Market Size by Type (2022-2027)
5 Breast Cancer Testing Breakdown Data by Application
5.1 Global Breast Cancer Testing Historic Market Size by Application (2016-2021)
5.2 Global Breast Cancer Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Breast Cancer Testing Market Size (2016-2027)
6.2 North America Breast Cancer Testing Market Size by Type
6.2.1 North America Breast Cancer Testing Market Size by Type (2016-2021)
6.2.2 North America Breast Cancer Testing Market Size by Type (2022-2027)
6.2.3 North America Breast Cancer Testing Market Size by Type (2016-2027)
6.3 North America Breast Cancer Testing Market Size by Application
6.3.1 North America Breast Cancer Testing Market Size by Application (2016-2021)
6.3.2 North America Breast Cancer Testing Market Size by Application (2022-2027)
6.3.3 North America Breast Cancer Testing Market Size by Application (2016-2027)
6.4 North America Breast Cancer Testing Market Size by Country
6.4.1 North America Breast Cancer Testing Market Size by Country (2016-2021)
6.4.2 North America Breast Cancer Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Breast Cancer Testing Market Size (2016-2027)
7.2 Europe Breast Cancer Testing Market Size by Type
7.2.1 Europe Breast Cancer Testing Market Size by Type (2016-2021)
7.2.2 Europe Breast Cancer Testing Market Size by Type (2022-2027)
7.2.3 Europe Breast Cancer Testing Market Size by Type (2016-2027)
7.3 Europe Breast Cancer Testing Market Size by Application
7.3.1 Europe Breast Cancer Testing Market Size by Application (2016-2021)
7.3.2 Europe Breast Cancer Testing Market Size by Application (2022-2027)
7.3.3 Europe Breast Cancer Testing Market Size by Application (2016-2027)
7.4 Europe Breast Cancer Testing Market Size by Country
7.4.1 Europe Breast Cancer Testing Market Size by Country (2016-2021)
7.4.2 Europe Breast Cancer Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Breast Cancer Testing Market Size (2016-2027)
8.2 Asia-Pacific Breast Cancer Testing Market Size by Type
8.2.1 Asia-Pacific Breast Cancer Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Breast Cancer Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Breast Cancer Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Breast Cancer Testing Market Size by Application
8.3.1 Asia-Pacific Breast Cancer Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Breast Cancer Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Breast Cancer Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Breast Cancer Testing Market Size by Region
8.4.1 Asia-Pacific Breast Cancer Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Breast Cancer Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Breast Cancer Testing Market Size (2016-2027)
9.2 Latin America Breast Cancer Testing Market Size by Type
9.2.1 Latin America Breast Cancer Testing Market Size by Type (2016-2021)
9.2.2 Latin America Breast Cancer Testing Market Size by Type (2022-2027)
9.2.3 Latin America Breast Cancer Testing Market Size by Type (2016-2027)
9.3 Latin America Breast Cancer Testing Market Size by Application
9.3.1 Latin America Breast Cancer Testing Market Size by Application (2016-2021)
9.3.2 Latin America Breast Cancer Testing Market Size by Application (2022-2027)
9.3.3 Latin America Breast Cancer Testing Market Size by Application (2016-2027)
9.4 Latin America Breast Cancer Testing Market Size by Country
9.4.1 Latin America Breast Cancer Testing Market Size by Country (2016-2021)
9.4.2 Latin America Breast Cancer Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Breast Cancer Testing Market Size (2016-2027)
10.2 Middle East & Africa Breast Cancer Testing Market Size by Type
10.2.1 Middle East & Africa Breast Cancer Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Breast Cancer Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Breast Cancer Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Breast Cancer Testing Market Size by Application
10.3.1 Middle East & Africa Breast Cancer Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Breast Cancer Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Breast Cancer Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Breast Cancer Testing Market Size by Country
10.4.1 Middle East & Africa Breast Cancer Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Breast Cancer Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Breast Cancer Testing Introduction
11.1.4 Abbott Revenue in Breast Cancer Testing Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Alere
11.2.1 Alere Company Details
11.2.2 Alere Business Overview
11.2.3 Alere Breast Cancer Testing Introduction
11.2.4 Alere Revenue in Breast Cancer Testing Business (2016-2021)
11.2.5 Alere Recent Development
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Details
11.3.2 Becton Dickinson Business Overview
11.3.3 Becton Dickinson Breast Cancer Testing Introduction
11.3.4 Becton Dickinson Revenue in Breast Cancer Testing Business (2016-2021)
11.3.5 Becton Dickinson Recent Development
11.4 BioMerieux
11.4.1 BioMerieux Company Details
11.4.2 BioMerieux Business Overview
11.4.3 BioMerieux Breast Cancer Testing Introduction
11.4.4 BioMerieux Revenue in Breast Cancer Testing Business (2016-2021)
11.4.5 BioMerieux Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Breast Cancer Testing Introduction
11.5.4 Roche Revenue in Breast Cancer Testing Business (2016-2021)
11.5.5 Roche Recent Development
11.6 GE Healthcare
11.6.1 GE Healthcare Company Details
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Breast Cancer Testing Introduction
11.6.4 GE Healthcare Revenue in Breast Cancer Testing Business (2016-2021)
11.6.5 GE Healthcare Recent Development
11.7 Hologic
11.7.1 Hologic Company Details
11.7.2 Hologic Business Overview
11.7.3 Hologic Breast Cancer Testing Introduction
11.7.4 Hologic Revenue in Breast Cancer Testing Business (2016-2021)
11.7.5 Hologic Recent Development
11.8 Philips
11.8.1 Philips Company Details
11.8.2 Philips Business Overview
11.8.3 Philips Breast Cancer Testing Introduction
11.8.4 Philips Revenue in Breast Cancer Testing Business (2016-2021)
11.8.5 Philips Recent Development
11.9 PerkinElmer
11.9.1 PerkinElmer Company Details
11.9.2 PerkinElmer Business Overview
11.9.3 PerkinElmer Breast Cancer Testing Introduction
11.9.4 PerkinElmer Revenue in Breast Cancer Testing Business (2016-2021)
11.9.5 PerkinElmer Recent Development
11.10 Quest Diagnostics
11.10.1 Quest Diagnostics Company Details
11.10.2 Quest Diagnostics Business Overview
11.10.3 Quest Diagnostics Breast Cancer Testing Introduction
11.10.4 Quest Diagnostics Revenue in Breast Cancer Testing Business (2016-2021)
11.10.5 Quest Diagnostics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Breast Cancer Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Screening Tests
Table 3. Key Players of Diagnostic Tests
Table 4. Key Players of Monitoring Tests
Table 5. Global Breast Cancer Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Breast Cancer Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Breast Cancer Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Breast Cancer Testing Market Share by Regions (2016-2021)
Table 9. Global Breast Cancer Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Breast Cancer Testing Market Share by Regions (2022-2027)
Table 11. Breast Cancer Testing Market Trends
Table 12. Breast Cancer Testing Market Drivers
Table 13. Breast Cancer Testing Market Challenges
Table 14. Breast Cancer Testing Market Restraints
Table 15. Global Breast Cancer Testing Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Breast Cancer Testing Market Share by Players (2016-2021)
Table 17. Global Top Breast Cancer Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Testing as of 2020)
Table 18. Ranking of Global Top Breast Cancer Testing Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Breast Cancer Testing Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Breast Cancer Testing Product Solution and Service
Table 22. Date of Enter into Breast Cancer Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Breast Cancer Testing Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Breast Cancer Testing Revenue Market Share by Type (2016-2021)
Table 26. Global Breast Cancer Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Breast Cancer Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Breast Cancer Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Breast Cancer Testing Revenue Market Share by Application (2016-2021)
Table 30. Global Breast Cancer Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Breast Cancer Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Breast Cancer Testing Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Breast Cancer Testing Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Breast Cancer Testing Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Breast Cancer Testing Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Breast Cancer Testing Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Breast Cancer Testing Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Breast Cancer Testing Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Breast Cancer Testing Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Breast Cancer Testing Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Breast Cancer Testing Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Breast Cancer Testing Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Breast Cancer Testing Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Breast Cancer Testing Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Breast Cancer Testing Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Breast Cancer Testing Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Breast Cancer Testing Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Breast Cancer Testing Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Breast Cancer Testing Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Breast Cancer Testing Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Breast Cancer Testing Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Breast Cancer Testing Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Breast Cancer Testing Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Breast Cancer Testing Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Breast Cancer Testing Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Breast Cancer Testing Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Breast Cancer Testing Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Breast Cancer Testing Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Breast Cancer Testing Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Breast Cancer Testing Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Breast Cancer Testing Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abbott Company Details
Table 63. Abbott Business Overview
Table 64. Abbott Breast Cancer Testing Product
Table 65. Abbott Revenue in Breast Cancer Testing Business (2016-2021) & (US$ Million)
Table 66. Abbott Recent Development
Table 67. Alere Company Details
Table 68. Alere Business Overview
Table 69. Alere Breast Cancer Testing Product
Table 70. Alere Revenue in Breast Cancer Testing Business (2016-2021) & (US$ Million)
Table 71. Alere Recent Development
Table 72. Becton Dickinson Company Details
Table 73. Becton Dickinson Business Overview
Table 74. Becton Dickinson Breast Cancer Testing Product
Table 75. Becton Dickinson Revenue in Breast Cancer Testing Business (2016-2021) & (US$ Million)
Table 76. Becton Dickinson Recent Development
Table 77. BioMerieux Company Details
Table 78. BioMerieux Business Overview
Table 79. BioMerieux Breast Cancer Testing Product
Table 80. BioMerieux Revenue in Breast Cancer Testing Business (2016-2021) & (US$ Million)
Table 81. BioMerieux Recent Development
Table 82. Roche Company Details
Table 83. Roche Business Overview
Table 84. Roche Breast Cancer Testing Product
Table 85. Roche Revenue in Breast Cancer Testing Business (2016-2021) & (US$ Million)
Table 86. Roche Recent Development
Table 87. GE Healthcare Company Details
Table 88. GE Healthcare Business Overview
Table 89. GE Healthcare Breast Cancer Testing Product
Table 90. GE Healthcare Revenue in Breast Cancer Testing Business (2016-2021) & (US$ Million)
Table 91. GE Healthcare Recent Development
Table 92. Hologic Company Details
Table 93. Hologic Business Overview
Table 94. Hologic Breast Cancer Testing Product
Table 95. Hologic Revenue in Breast Cancer Testing Business (2016-2021) & (US$ Million)
Table 96. Hologic Recent Development
Table 97. Philips Company Details
Table 98. Philips Business Overview
Table 99. Philips Revenue in Breast Cancer Testing Business (2016-2021) & (US$ Million)
Table 100. Philips Recent Development
Table 101. PerkinElmer Company Details
Table 102. PerkinElmer Business Overview
Table 103. PerkinElmer Breast Cancer Testing Product
Table 104. PerkinElmer Revenue in Breast Cancer Testing Business (2016-2021) & (US$ Million)
Table 105. PerkinElmer Recent Development
Table 106. Quest Diagnostics Company Details
Table 107. Quest Diagnostics Business Overview
Table 108. Quest Diagnostics Breast Cancer Testing Product
Table 109. Quest Diagnostics Revenue in Breast Cancer Testing Business (2016-2021) & (US$ Million)
Table 110. Quest Diagnostics Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Breast Cancer Testing Market Share by Type: 2020 VS 2027
Figure 2. Screening Tests Features
Figure 3. Diagnostic Tests Features
Figure 4. Monitoring Tests Features
Figure 5. Global Breast Cancer Testing Market Share by Application: 2020 VS 2027
Figure 6. Non-invasive Breast Cancer Case Studies
Figure 7. Invasive Breast Cancer Case Studies
Figure 8. Breast Cancer Testing Report Years Considered
Figure 9. Global Breast Cancer Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Breast Cancer Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Breast Cancer Testing Market Share by Regions: 2020 VS 2027
Figure 12. Global Breast Cancer Testing Market Share by Regions (2022-2027)
Figure 13. Global Breast Cancer Testing Market Share by Players in 2020
Figure 14. Global Top Breast Cancer Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Testing as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Breast Cancer Testing Revenue in 2020
Figure 16. Global Breast Cancer Testing Revenue Market Share by Type (2016-2021)
Figure 17. Global Breast Cancer Testing Revenue Market Share by Type (2022-2027)
Figure 18. North America Breast Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Breast Cancer Testing Market Share by Type (2016-2027)
Figure 20. North America Breast Cancer Testing Market Share by Application (2016-2027)
Figure 21. North America Breast Cancer Testing Market Share by Country (2016-2027)
Figure 22. United States Breast Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Breast Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Breast Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Breast Cancer Testing Market Share by Type (2016-2027)
Figure 26. Europe Breast Cancer Testing Market Share by Application (2016-2027)
Figure 27. Europe Breast Cancer Testing Market Share by Country (2016-2027)
Figure 28. Germany Breast Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Breast Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Breast Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Breast Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Breast Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Breast Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Breast Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Breast Cancer Testing Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Breast Cancer Testing Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Breast Cancer Testing Market Share by Region (2016-2027)
Figure 38. China Breast Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Breast Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Breast Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Breast Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Breast Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Breast Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Breast Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Breast Cancer Testing Market Share by Type (2016-2027)
Figure 46. Latin America Breast Cancer Testing Market Share by Application (2016-2027)
Figure 47. Latin America Breast Cancer Testing Market Share by Country (2016-2027)
Figure 48. Mexico Breast Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Breast Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Breast Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Breast Cancer Testing Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Breast Cancer Testing Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Breast Cancer Testing Market Share by Country (2016-2027)
Figure 54. Turkey Breast Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Breast Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Breast Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Abbott Revenue Growth Rate in Breast Cancer Testing Business (2016-2021)
Figure 58. Alere Revenue Growth Rate in Breast Cancer Testing Business (2016-2021)
Figure 59. Becton Dickinson Revenue Growth Rate in Breast Cancer Testing Business (2016-2021)
Figure 60. BioMerieux Revenue Growth Rate in Breast Cancer Testing Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in Breast Cancer Testing Business (2016-2021)
Figure 62. GE Healthcare Revenue Growth Rate in Breast Cancer Testing Business (2016-2021)
Figure 63. Hologic Revenue Growth Rate in Breast Cancer Testing Business (2016-2021)
Figure 64. Philips Revenue Growth Rate in Breast Cancer Testing Business (2016-2021)
Figure 65. PerkinElmer Revenue Growth Rate in Breast Cancer Testing Business (2016-2021)
Figure 66. Quest Diagnostics Revenue Growth Rate in Breast Cancer Testing Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
乳がん検査のグローバル市場：規模・現状・予測2019-2025 Breast cancer is one of the most common malignant tumors in women, which poses a great threat to women's life and health.In recent years, as people pay more attention to women's health, the detection methods of their diseases have been greatly improved.Breast cancer tests include screening tests, di…- 乳がん検査のグローバル市場：規模・現状・予測2019-2025 Breast cancer is one of the most common malignant tumors in women, which poses a great threat to women's life and health.In recent years, as people pay more attention to women's health, the detection methods of their diseases have been greatly improved.Breast cancer tests include screening tests, di…
- 世界の乳がん診断市場規模・現状・予測（2021年-2027年） Breast cancer can be diagnosed through multiple tests, including a mammogram, ultrasound, MRI and biopsy. Market Analysis and Insights: Global Breast Cancer Diagnostic Market The global Breast Cancer Diagnostic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, a…
- 世界の乳がん診断＆薬物技術市場規模・現状・予測（2021年-2027年） Breast cancer is a malignant tumor that occurs in the epithelial tissue of the breast gland.Breast Cancer Diagnostic and Drug Technologies include mammography, biopsy and so on. Market Analysis and Insights: Global Breast Cancer Diagnostic and Drug Technologies Market The global Breast Cancer Diagno…
- 世界の乳がん分子病理学診断市場規模・現状・予測（2021年-2027年） A molecular approach for women to diagnose breast cancer Market Analysis and Insights: Global Breast Cancer Molecular Diagnostics Market The global Breast Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-…